跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,364 条关于
“interleukin 23 subunit alpha”
全部
8,364
临床试验
3,598
药物
1,595
机构
144
资讯
3,027
去年
Celltrion's Ustekinumab Biosimilar (CTP-43) Enters Pre-Registration for Psoriatic Arthritis
去年
FDA Approves Additional Presentation for Alvotech and Teva's Ustekinumab Biosimilar
去年
Tocilizumab Investigated for Acute Myocardial Infarction with Cardiogenic Shock
6年前
Immunology Market Evolution: Interleukin Inhibitors Rise as Biosimilars Reshape Treatment Landscape
去年
FDA Approves New Intravenous Formulation of Ustekinumab Biosimilar SELARSDI™
去年
Qyuns Therapeutics' Ustekinumab Biosimilar Approved in China for Psoriasis Treatment
去年
Severe Asthma Pipeline Shows Promise with Over 50 Therapies in Development
去年
FDA Approves Accord BioPharma's IMULDOSA (Ustekinumab-srlf) as Biosimilar
去年
Keymed Biosciences' Stapokibart Receives NMPA Approval for Seasonal Allergic Rhinitis and Chronic Rhinosinusitis with Nasal Polyposis
去年
Novel Monoclonal Antibody Stapokibart Demonstrates Significant Efficacy in Severe Chronic Rhinosinusitis with Nasal Polyps
第 1 页，共 303 页
上一页
下一页
